NCT03414931View on ClinicalTrials.gov

NMDA Modulation in Major Depressive Disorder in Late- Life

PHASE2CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Depressive Disorder, Major
Interventions
DRUG

NMDA

Use of an NMDA enhancer for the treatment of MDD in late life

DRUG

Sertraline

Use of SSRI as an active comparator

DRUG

Placebo - Cap

Use of placebo as a comparator

Trial Locations (2)

404

China Medical University Hospital, Taichung

886

Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT03414931 - NMDA Modulation in Major Depressive Disorder in Late- Life | Biotech Hunter | Biotech Hunter